Intercept Pharmaceuticals, Inc.
Overview
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. It is known for its research and development in areas like Primary Biliary Cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Intercept Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Intercept Pharmaceuticals, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.